Search Results - "Heerspink, H.J. Lambers"

18F-Fdg Uptake In Visceral Adipose Tissue Is Inversely Associated To Insulin Resistance And Adiponectin by Reijrink, M., De Boer, S.A., Spoor, D.S., Antunes, I. Farinha, Greuter, M.J.W., Pol, R.A., Heerspink, H.J. Lambers, Hillebrands, J.L., Slart, R.H.J.A., Mulder, D.J.

Get full text

Creatinine-excretie en mortaliteit in type 2 diabetes en nefropathie by Sinkeler, S.J., Kwakernaak, A.J., Bakker, S.J.L., Shahinfar, S., Esmatjes, E., de Zeeuw, D., Navis, G.J., Lambers Heerspink, H.J.

Get full text

Is doubling of serum creatinine a valid clinical 'hard' endpoint in clinical nephrology trials? by Lambers Heerspink, H J, Perkovic, V, de Zeeuw, D

“…The composite of end stage renal disease (ESRD), doubling of serum creatinine and (renal) death, is a frequently used endpoint in randomized clinical trials in…”
Get more information

Dual RAS therapy not on target, but fully alive by Lambers Heerspink, H J, de Zeeuw, D

“…Inhibitors of the renin-angiotensin system (RAS) form a cornerstone in the treatment of kidney disease. These drugs lower blood pressure and albuminuria, and…”
Get more information

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics by Lambers Heerspink, H J, Agarwal, R, Coyne, D W, Parving, H-H, Ritz, E, Remuzzi, G, Audhya, P, Amdahl, M J, Andress, D L, de Zeeuw, D

“…Patients with diabetic nephropathy are at high risk for further progressive renal function loss. Treatments that decrease albuminuria have been linked with…”
Get more information

On- en off-targeteffecten van dipeptidyl peptidase-4-remmers: Een ideaal middel voor diabetespreventie en mogelijk ook beschermend tegen cardiovasculaire schade? by Mulder, D.J., Lambers Heerspink, H.J., Lefrandt, J.D.

Get full text

27. Dapagliflozin Reduces Albuminuria on Top of Renin-Angiotensin System Blockade in Hypertensive Diabetic Patients (1176-P) by Heerspink, H.J. Lambers, Johnsson, Eva, Gause-Nilsson, Ingrid, Johansson, Kristoffer, Sjöström, C. David

Get full text

Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection by Lambers Heerspink, H J

“…Blood pressure is a strong risk factor for ischemic and atherosclerotic events such as stroke. Blood pressure is often elevated in patients with chronic kidney…”
Get more information